Morgan Stanley’s Beneficient BENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166K Buy
45,122
+21,084
+88% +$73.3K ﹤0.01% 6038
2026
Q1
$84.1K Buy
+24,038
New +$104K ﹤0.01% 6233
2023
Q4
Hold
0
-$648 7831
2023
Q3
Hold
0
7281

Other funds holding BENF

Morgan Stanley's BENF Position: Q2 2026 in Review

Morgan Stanley increased its Beneficient (BENF) stake by 88% in Q2 2026, buying an estimated $73.3K and bringing the position to 45,122 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #6038.

Morgan Stanley first reported a position in BENF in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold BENF as of Q2 2026.

  • Morgan Stanley held 45,122 shares of Beneficient worth $166K as of Q2 2026.
  • Morgan Stanley bought 21,084 Beneficient shares in Q2 2026, an estimated $73.3K.
  • Beneficient made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6038 holding.
  • Morgan Stanley first reported a position in Beneficient in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Beneficient as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.